Global stock markets traded flat today as the count of coronavirus cases rose in multiple major economies, resulting in more business limitations.

Independent monitors temporarily halted enrollment Tuesday in testing Eli Lilly and Co.’s (NYSE: LLY) COVID-19 experimental antibody therapy “out of an abundance of caution.” This came after Johnson & Johnson (NYSE: JNJ) paused its late-stage vaccine study due to a participant’s “unexplained illness.”

But virus vaccine setbacks aren’t the only thing hanging over the stock market…

In today’s video, I’ll show you how COVID-19 is impacting the major indexes… how earnings are influencing the overall market… a warning sign on current momentum levels in large-cap tech stocks… and two low-risk entry opportunities with risk stops. 

My Top Stocks Ahead of the Fed’s Next Rate Hike

My Top Stocks Ahead of the Fed’s Next Rate Hike

 Before we begin, I want to let you know that this morning's Trading Pub Roundtable with Don Yocham — featuring Tactical Wealth Investor’s Garrett Baldwin, Austrian trading expert Achim Mautz and yours truly, Senior Strategist Roger Scott — will be held at our new...

read more